Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms- |
Target |
Action degraders |
Mechanism BRD7 degraders(Bromodomain-containing protein 7 degraders), BRD9 degraders(Bromodomain-containing protein 9 degraders) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC52H63FN8O9S |
InChIKeyWQNUXIHALDIEAE-QRYWEXOJSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | Austria | 12 Dec 2018 | |
Neoplasms | Preclinical | Italy | 12 Dec 2018 | |
Neoplasms | Preclinical | United Kingdom | 12 Dec 2018 |